Combat
injuries are associated with a high incidence of
infection, and there is a continuing need for improved approaches to control infection and promote wound healing. Due to the possible local and systemic adverse effects of standard 1% cream formulation (
Silvadene), we had previously developed a
polyethylene glycol (PEGylated)
fibrin hydrogel (FPEG)-based
wound dressing for the controlled delivery of
silver sulfadiazine (
SSD) entrapped in
chitosan microspheres (CSM). In this study, we have evaluated the antimicrobial and wound healing efficacy of
SSD-CSM-FPEG using a full-thickness porcine
wound infected with Pseudomonas aeruginosa. Infected
wounds treated with a one-time application of the
SSD-CSM-FPEG
wound dressing demonstrated significantly reduced bacterial bioburden over time (99·99% of reduction by day 11; P < 0·05) compared with all the other treatment groups. The epithelial thickness and granulation of the
wound bed was significantly better on day 7 (150·9 ± 13·12 µm), when compared with other treatment groups. Overall, our findings demonstrate that the
SSD-CSM-FPEG
wound dressing effectively controls P. aeruginosa
infection and promotes wound healing by providing a favourable environment that induces neovascularisation. Collectively, sustained release of
SSD using
fibrin hydrogel exhibited enhanced benefits when compared with the currently available
SSD treatment, and this may have significant implications in the bacterial reduction of infected
wounds in military and civilian populations.